Jerzy Gumulka SEC EDGAR Filings (CIK 0001793252)

SEC EDGAR filings, ownership reports, and insider transactions for Jerzy Gumulka.

Business address
C/O Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston, TX, 77027
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jerzy Gumulka has filed 10 SEC EDGAR filings since 08 Nov 2019

Latest Filings

Recent SEC filings for Jerzy Gumulka including 4, 4/A, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 19 Nov 2025 17 Nov 2025 001-39126
4 Open 4 document View SEC filing for 4 10 Apr 2024 08 Apr 2024 001-39126
4 Open 4 document View SEC filing for 4 06 Feb 2024 01 Feb 2024 001-39126
4/A Open 4/A document View SEC filing for 4/A 12 Oct 2023 21 Sep 2023 001-39126
4 Open 4 document View SEC filing for 4 25 Sep 2023 21 Sep 2023 001-39126
4 Open 4 document View SEC filing for 4 21 Apr 2023 19 Apr 2023 001-39126
4 Open 4 document View SEC filing for 4 17 Apr 2023 10 Apr 2023 001-39126
4 Open 4 document View SEC filing for 4 16 Jul 2021 15 Jul 2021 001-39126
4 Open 4 document View SEC filing for 4 16 Jun 2020 12 Jun 2020 001-39126
3 Open 3 document View SEC filing for 3 08 Nov 2019 07 Nov 2019 001-39126

About this filer

Jerzy Gumulka files with the SEC under CIK 0001793252. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages